• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ATP结合盒亚家族B成员9(ABCB9)是卵巢癌总生存期的一个预后指标。

ATP binding cassette subfamily B member 9 (ABCB9) is a prognostic indicator of overall survival in ovarian cancer.

作者信息

Hou Lin, Zhang Xueying, Jiao Yan, Li Yanqing, Zhao Yuechen, Guan Yinuo, Liu Ziling

机构信息

Cancer Center, The First Hospital of Jilin University.

Reproductive Medical Center, Department of Obstetrics and Gynecology, The Second Hospital of Jilin University.

出版信息

Medicine (Baltimore). 2019 May;98(19):e15698. doi: 10.1097/MD.0000000000015698.

DOI:10.1097/MD.0000000000015698
PMID:31083274
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6531167/
Abstract

Ovarian cancer (OC) is one of the most common gynecological malignancies and owns the highest mortality rate among all gynecological malignant tumors. ATP binding cassette subfamily B member 9 (ABCB9) is an antigen processing-like (TAPL) transporter that has been found to be involved in the development and progression of various malignant tumors in accumulating reports. However, the potential role of ABCB9 in OC has never been reported.In this study, ABCB9 expression was evaluated in normal ovarian tissues and ovarian cancer tissues using The Cancer Genome Atlas (TCGA) database. And the associations between ABCB9 expression and clinical parameters of patients of OC were evaluated by Chi-square tests. Kaplan-Meier analysis and Cox regression analysis were performed to evaluate the prognostic significance of ABCB9. GSEA was performed to explore related signaling pathway.ABCB9 expression levels were significantly decreased in OC compared with normal ovarian tissues (P < .001). Low ABCB9 expression was associated with survival status (P = .0148) in OC. Kaplan-Meier analysis showed that low ABCB9 expression was associated with poor overall survival in OC (P = .0032). Multivariable Cox regression analysis indicated that low ABCB9 expression was an independent prognostic factor (HR 0.64; P = .01) in OC patients. Besides, epithelial mesenchymal transition, UV response, and TGF-β signaling were enriched in low ABCB9 expression phenotype, respectively, examined by gene set enrichment analysis.These results suggest that ABCB9 is an independent prognostic indicator in OC with certain clinical significance.

摘要

卵巢癌(OC)是最常见的妇科恶性肿瘤之一,在所有妇科恶性肿瘤中死亡率最高。ATP结合盒亚家族B成员9(ABCB9)是一种抗原加工样(TAPL)转运蛋白,越来越多的报道发现它参与了各种恶性肿瘤的发生和发展。然而,ABCB9在OC中的潜在作用尚未见报道。在本研究中,使用癌症基因组图谱(TCGA)数据库评估了正常卵巢组织和卵巢癌组织中ABCB9的表达。通过卡方检验评估ABCB9表达与OC患者临床参数之间的关联。进行Kaplan-Meier分析和Cox回归分析以评估ABCB9的预后意义。进行基因集富集分析(GSEA)以探索相关信号通路。与正常卵巢组织相比,OC中ABCB9表达水平显著降低(P<0.001)。低ABCB9表达与OC患者的生存状态相关(P=0.0148)。Kaplan-Meier分析表明,低ABCB9表达与OC患者较差的总生存期相关(P=0.0032)。多变量Cox回归分析表明,低ABCB9表达是OC患者的独立预后因素(HR 0.64;P=0.01)。此外,通过基因集富集分析检测发现,上皮-间质转化、紫外线反应和TGF-β信号通路在低ABCB9表达表型中分别富集。这些结果表明,ABCB9是OC的独立预后指标,具有一定的临床意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c922/6531167/5c666bc18a0d/medi-98-e15698-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c922/6531167/ec107c98f093/medi-98-e15698-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c922/6531167/6bd937f85fd4/medi-98-e15698-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c922/6531167/5c666bc18a0d/medi-98-e15698-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c922/6531167/ec107c98f093/medi-98-e15698-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c922/6531167/6bd937f85fd4/medi-98-e15698-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c922/6531167/5c666bc18a0d/medi-98-e15698-g007.jpg

相似文献

1
ATP binding cassette subfamily B member 9 (ABCB9) is a prognostic indicator of overall survival in ovarian cancer.ATP结合盒亚家族B成员9(ABCB9)是卵巢癌总生存期的一个预后指标。
Medicine (Baltimore). 2019 May;98(19):e15698. doi: 10.1097/MD.0000000000015698.
2
Adenylate kinase 7 is a prognostic indicator of overall survival in ovarian cancer.腺苷酸激酶 7 是卵巢癌总生存期的预后指标。
Medicine (Baltimore). 2021 Jan 8;100(1):e24134. doi: 10.1097/MD.0000000000024134.
3
Decreased expression of ALDH5A1 predicts prognosis in patients with ovarian cancer.ALDH5A1表达降低可预测卵巢癌患者的预后。
Cancer Biol Ther. 2017 Apr 3;18(4):245-251. doi: 10.1080/15384047.2017.1295175. Epub 2017 Mar 27.
4
[Relationships between decreased LAMC3 and poor prognosis in ovarian cancer].[层粘连蛋白γ3(LAMC3)降低与卵巢癌预后不良的关系]
Zhonghua Fu Chan Ke Za Zhi. 2021 Jul 25;56(7):489-497. doi: 10.3760/cma.j.cn112141-20210426-00230.
5
SORL1 stabilizes ABCB1 to promote cisplatin resistance in ovarian cancer.SORL1 稳定 ABCB1 以促进卵巢癌对顺铂的耐药性。
Funct Integr Genomics. 2023 May 5;23(2):147. doi: 10.1007/s10142-023-01075-3.
6
Low EIF2B5 expression predicts poor prognosis in ovarian cancer.低EIF2B5表达预示卵巢癌预后不良。
Medicine (Baltimore). 2020 Jan;99(5):e18666. doi: 10.1097/MD.0000000000018666.
7
Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.miR-182 在卵巢癌中的预后价值及潜在通路信号分析:基于基因表达综合数据库(GEO)和生物信息学分析的研究。
J Ovarian Res. 2019 Nov 8;12(1):106. doi: 10.1186/s13048-019-0580-7.
8
ABCA transporter gene expression and poor outcome in epithelial ovarian cancer.ABCA 转运蛋白基因表达与上皮性卵巢癌不良预后的关系。
J Natl Cancer Inst. 2014 Jun 23;106(7). doi: 10.1093/jnci/dju149. Print 2014 Jul.
9
Increased Expression of Predicting Poor Survival of Epithelial Ovarian Cancer: Based on Comprehensive Analysis of , Clinical Samples, and the GEO Database.基于临床样本和 GEO 数据库的综合分析,上调的 预测上皮性卵巢癌不良预后:
DNA Cell Biol. 2021 Jan;40(1):36-60. doi: 10.1089/dna.2020.5823. Epub 2020 Nov 11.
10
Human epithelial-type ovarian tumour marker beta-2-microglobulin is regulated by the TGF-β signaling pathway.人类上皮型卵巢肿瘤标志物β2微球蛋白受转化生长因子-β信号通路调控。
J Transl Med. 2016 Mar 16;14:75. doi: 10.1186/s12967-016-0832-x.

引用本文的文献

1
Top-Down Proteomic Profiling of Protein Corona by High-Throughput Capillary Isoelectric Focusing-Mass Spectrometry.通过高通量毛细管等电聚焦-质谱法对蛋白质冠层进行自上而下的蛋白质组学分析
J Am Soc Mass Spectrom. 2025 Apr 2;36(4):778-786. doi: 10.1021/jasms.4c00463. Epub 2025 Mar 2.
2
Tumor Microenvironment in Oral Squamous Cell Carcinoma: Special Stains and Scanning Electron Microscopic Study.口腔鳞状细胞癌中的肿瘤微环境:特殊染色及扫描电子显微镜研究
J Microsc Ultrastruct. 2022 Nov 14;12(3):148-154. doi: 10.4103/jmau.jmau_19_22. eCollection 2024 Jul-Sep.
3
Suppression of lysosome metabolism-meditated GARP/TGF-β1 complexes specifically depletes regulatory T cells to inhibit breast cancer metastasis.

本文引用的文献

1
Aberrant FAM64A mRNA expression is an independent predictor of poor survival in pancreatic cancer.FAM64A mRNA 表达异常是胰腺癌患者生存不良的独立预测因子。
PLoS One. 2019 Jan 29;14(1):e0211291. doi: 10.1371/journal.pone.0211291. eCollection 2019.
2
High EIF2B5 mRNA expression and its prognostic significance in liver cancer: a study based on the TCGA and GEO database.高EIF2B5 mRNA表达及其在肝癌中的预后意义:基于TCGA和GEO数据库的研究
Cancer Manag Res. 2018 Nov 20;10:6003-6014. doi: 10.2147/CMAR.S185459. eCollection 2018.
3
MicroRNA-31-5p regulates chemosensitivity by preventing the nuclear location of PARP1 in hepatocellular carcinoma.
抑制溶酶体代谢介导的 GARP/TGF-β1 复合物可特异性耗竭调节性 T 细胞,从而抑制乳腺癌转移。
Oncogene. 2024 Jun;43(25):1930-1940. doi: 10.1038/s41388-024-03043-y. Epub 2024 May 2.
4
Role of Metabolomics in Pathogenesis and Prompt Diagnosis of Gastric Cancer Metastasis-A Systematic Review.代谢组学在胃癌转移发病机制及快速诊断中的作用——一项系统综述
Diagnostics (Basel). 2023 Nov 8;13(22):3401. doi: 10.3390/diagnostics13223401.
5
polymorphism rs61955196 is associated with schizophrenia in a Chinese Han population.多态性rs61955196与中国汉族人群的精神分裂症相关。
World J Psychiatry. 2022 Jul 19;12(7):904-914. doi: 10.5498/wjp.v12.i7.904.
6
miR 31-3p Has the Highest Expression in Cesarean Scar Endometriosis.miR 31-3p 在剖宫产瘢痕内异症中表达最高。
Int J Mol Sci. 2022 Apr 22;23(9):4660. doi: 10.3390/ijms23094660.
7
KLRK1 as a prognostic biomarker for lung adenocarcinoma cancer.KLKR1 作为肺腺癌的预后生物标志物。
Sci Rep. 2022 Feb 7;12(1):1976. doi: 10.1038/s41598-022-05997-z.
8
Expression and clinical significance of BDH1 in liver cancer.肝癌中 BDH1 的表达及临床意义。
Medicine (Baltimore). 2021 Dec 3;100(48):e28013. doi: 10.1097/MD.0000000000028013.
9
Dissecting the Transcriptomes of Multiple Metronidazole-Resistant and Sensitive Strains Identified Distinct Genes and Pathways Associated with Drug Resistance and Cell Death.剖析多个甲硝唑耐药和敏感菌株的转录组,鉴定出与耐药性和细胞死亡相关的不同基因和通路。
Biomedicines. 2021 Dec 2;9(12):1817. doi: 10.3390/biomedicines9121817.
10
Is a Prognostic Biomarker Correlated With Immune Infiltration in Hepatocellular Carcinoma.是一种与肝细胞癌免疫浸润相关的预后生物标志物。
Front Oncol. 2021 Sep 14;11:713017. doi: 10.3389/fonc.2021.713017. eCollection 2021.
microRNA-31-5p 通过防止 PARP1 的核定位来调节肝癌的化疗敏感性。
J Exp Clin Cancer Res. 2018 Nov 6;37(1):268. doi: 10.1186/s13046-018-0930-0.
4
Diagnosis and Treatment of Ovarian Cancer.卵巢癌的诊断与治疗
Hematol Oncol Clin North Am. 2018 Dec;32(6):943-964. doi: 10.1016/j.hoc.2018.07.010.
5
High Trophinin-Associated Protein Expression Is an Independent Predictor of Poor Survival in Liver Cancer.高肿瘤蛋白相关蛋白表达是肝癌不良生存的独立预测因子。
Dig Dis Sci. 2019 Jan;64(1):137-143. doi: 10.1007/s10620-018-5315-x. Epub 2018 Oct 4.
6
ATP-binding cassette transporters in progression and clinical outcome of pancreatic cancer: What is the way forward?ATP 结合盒转运蛋白在胰腺癌进展和临床结局中的作用:未来的方向是什么?
World J Gastroenterol. 2018 Aug 7;24(29):3222-3238. doi: 10.3748/wjg.v24.i29.3222.
7
Ovarian cancer: how can resistance to chemotherapy be tackled?卵巢癌:如何应对化疗耐药问题?
Future Oncol. 2017 Dec;13(30):2737-2739. doi: 10.2217/fon-2017-0235. Epub 2017 Nov 28.
8
Ex vivo retrieval and cryopreservation of oocytes from oophorectomized specimens for fertility preservation in a BRCA1 mutation carrier with ovarian cancer.从卵巢癌 BRCA1 突变携带者的卵巢切除标本中体外获取和冷冻保存卵母细胞以进行生育力保存。
Fertil Steril. 2017 Aug;108(2):357-360. doi: 10.1016/j.fertnstert.2017.05.025. Epub 2017 Jun 16.
9
The FOXM1-ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells.FOXM1-ABCC5轴在鼻咽癌细胞中导致对紫杉醇耐药。
Cell Death Dis. 2017 Mar 9;8(3):e2659. doi: 10.1038/cddis.2017.53.
10
Cancer Statistics, 2017.《2017 年癌症统计》
CA Cancer J Clin. 2017 Jan;67(1):7-30. doi: 10.3322/caac.21387. Epub 2017 Jan 5.